| Immunomodulation-accelerated neuronal regeneration following selective rod photoreceptor cell ablation in the zebrafish retina DT White, S Sengupta, MT Saxena, Q Xu, J Hanes, D Ding, H Ji, ... Proceedings of the National Academy of Sciences 114 (18), E3719-E3728, 2017 | 145 | 2017 |
| Circulating tumor DNA as a clinical test in resected pancreatic cancer VP Groot, S Mosier, AA Javed, JA Teinor, G Gemenetzis, D Ding, ... Clinical Cancer Research 25 (16), 4973-4984, 2019 | 139 | 2019 |
| Circulating tumor cells dynamics in pancreatic adenocarcinoma correlate with disease status: results of the prospective CLUSTER study G Gemenetzis, VP Groot, J Yu, D Ding, JA Teinor, AA Javed, LD Wood, ... Annals of surgery 268 (3), 408-420, 2018 | 138 | 2018 |
| Axon guidance molecules promote perineural invasion and metastasis of orthotopic pancreatic tumors in mice NR Jurcak, AA Rucki, S Muth, E Thompson, R Sharma, D Ding, Q Zhu, ... Gastroenterology 157 (3), 838-850. e6, 2019 | 109 | 2019 |
| Negative pressure wound therapy for surgical-site infections: a randomized trial AA Javed, J Teinor, M Wright, D Ding, RA Burkhart, J Hundt, JL Cameron, ... Annals of surgery 269 (6), 1034-1040, 2019 | 107 | 2019 |
| Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma VP Groot, G Gemenetzis, AB Blair, D Ding, AA Javed, RA Burkhart, J Yu, ... Annals of surgical oncology 25, 2475-2483, 2018 | 83 | 2018 |
| Main duct dilatation is the best predictor of high-grade dysplasia or invasion in intraductal papillary mucinous neoplasms of the pancreas M Del Chiaro, R Beckman, Z Ateeb, N Orsini, N Rezaee, L Manos, ... Annals of surgery 272 (6), 1118-1124, 2020 | 80 | 2020 |
| Efficacy of crizotinib among different types of ROS1 fusion partners in patients with ROS1-rearranged non–small cell lung cancer Z Li, L Shen, D Ding, J Huang, J Zhang, Z Chen, S Lu Journal of Thoracic Oncology 13 (7), 987-995, 2018 | 79 | 2018 |
| Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer VP Groot, AB Blair, G Gemenetzis, D Ding, RA Burkhart, J Yu, ... European Journal of Surgical Oncology 45 (9), 1674-1683, 2019 | 71 | 2019 |
| Outcome of patients with borderline resectable pancreatic cancer in the contemporary era of neoadjuvant chemotherapy AA Javed, MJ Wright, A Siddique, AB Blair, D Ding, RA Burkhart, ... Journal of Gastrointestinal Surgery 23, 112-121, 2019 | 71 | 2019 |
| Circulating Micro RNA‐188,‐30a, and‐30e as Early Biomarkers for Contrast‐Induced Acute Kidney Injury S Sun, T Zhang, D Ding, W Zhang, X Wang, Z Sun, L Hu, S Qin, L Shen, ... Journal of the American Heart Association 5 (8), e004138, 2016 | 67 | 2016 |
| Perioperative outcomes of robotic pancreaticoduodenectomy: a propensity-matched analysis to open and laparoscopic pancreaticoduodenectomy AF van Oosten, D Ding, JR Habib, A Irfan, RK Schmocker, E Sereni, ... Journal of Gastrointestinal Surgery 25 (7), 1795-1804, 2021 | 54 | 2021 |
| Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer MT Saung, S Muth, D Ding, DL Thomas, AB Blair, T Tsujikawa, ... Journal for immunotherapy of cancer 6, 1-11, 2018 | 52 | 2018 |
| The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung … D Ding, Y Yu, Z Li, X Niu, S Lu OncoTargets and therapy, 387-393, 2014 | 47 | 2014 |
| ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates DT White, AU Eroglu, G Wang, L Zhang, S Sengupta, D Ding, ... Nature protocols 11 (12), 2432-2453, 2016 | 42 | 2016 |
| Impact of margin status on survival in patients with pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy RK Schmocker, D Delitto, MJ Wright, D Ding, JL Cameron, KJ Lafaro, ... Journal of the American College of Surgeons 232 (4), 405-413, 2021 | 39 | 2021 |
| Vaccine-induced intratumoral lymphoid aggregates correlate with survival following treatment with a neoadjuvant and adjuvant vaccine in patients with resectable pancreatic … L Zheng, D Ding, BH Edil, C Judkins, JN Durham, DL Thomas, KM Bever, ... Clinical Cancer Research 27 (5), 1278-1286, 2021 | 36 | 2021 |
| An aggressive approach to locally confined pancreatic cancer: defining surgical and oncologic outcomes unique to pancreatectomy with celiac axis resection (DP-CAR) RK Schmocker, MJ Wright, D Ding, MJ Beckman, AA Javed, JL Cameron, ... Annals of surgical oncology 28, 3125-3134, 2021 | 34 | 2021 |
| First‐line crizotinib versus platinum‐pemetrexed chemotherapy in patients with advanced ROS1‐rearranged non‐small‐cell lung cancer L Shen, T Qiang, Z Li, D Ding, Y Yu, S Lu Cancer Medicine 9 (10), 3310-3318, 2020 | 34 | 2020 |
| NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation AV Sharrock, TS Mulligan, KR Hall, EM Williams, DT White, L Zhang, ... Nature methods 19 (2), 205-215, 2022 | 33 | 2022 |
